BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20502053)

  • 1. The role of prokineticins in the pathogenesis of hypogonadotropic hypogonadism.
    Abreu AP; Kaiser UB; Latronico AC
    Neuroendocrinology; 2010; 91(4):283-90. PubMed ID: 20502053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prokineticins in central and peripheral control of human reproduction.
    Traboulsi W; Brouillet S; Sergent F; Boufettal H; Samouh N; Aboussaouira T; Hoffmann P; Feige JJ; Benharouga M; Alfaidy N
    Horm Mol Biol Clin Investig; 2015 Nov; 24(2):73-81. PubMed ID: 26574895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.
    Martin C; Balasubramanian R; Dwyer AA; Au MG; Sidis Y; Kaiser UB; Seminara SB; Pitteloud N; Zhou QY; Crowley WF
    Endocr Rev; 2011 Apr; 32(2):225-46. PubMed ID: 21037178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokineticins and their G protein-coupled receptors in health and disease.
    Zhao Y; Wu J; Wang X; Jia H; Chen DN; Li JD
    Prog Mol Biol Transl Sci; 2019; 161():149-179. PubMed ID: 30711026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
    Sarfati J; Dodé C; Young J
    Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
    Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
    PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prokineticin Ligands and Receptors Are Expressed in the Human Fetal Ovary and Regulate Germ Cell Expression of COX2.
    Eddie SL; Childs AJ; Kinnell HL; Brown P; Jabbour HN; Anderson RA
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1197-205. PubMed ID: 26192875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of PROKR1 and PROKR2 in human enteric neural precursor cells and identification of sequence variants suggest a role in HSCR.
    Ruiz-Ferrer M; Torroglosa A; Núñez-Torres R; de Agustín JC; Antiñolo G; Borrego S
    PLoS One; 2011; 6(8):e23475. PubMed ID: 21858136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma.
    Lauttia S; Sihto H; Kavola H; Koljonen V; Böhling T; Joensuu H
    Br J Cancer; 2014 Mar; 110(6):1446-55. PubMed ID: 24496457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
    Sarfati J; Guiochon-Mantel A; Rondard P; Arnulf I; Garcia-Piñero A; Wolczynski S; Brailly-Tabard S; Bidet M; Ramos-Arroyo M; Mathieu M; Lienhardt-Roussie A; Morgan G; Turki Z; Bremont C; Lespinasse J; Du Boullay H; Chabbert-Buffet N; Jacquemont S; Reach G; De Talence N; Tonella P; Conrad B; Despert F; Delobel B; Brue T; Bouvattier C; Cabrol S; Pugeat M; Murat A; Bouchard P; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2010 Feb; 95(2):659-69. PubMed ID: 20022991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PROK2/PROKR2 signaling pathway is required for the migration of most olfactory bulb interneurons.
    Wen Y; Zhang Z; Li Z; Liu G; Tao G; Song X; Xu Z; Shang Z; Guo T; Su Z; Chen H; You Y; Li J; Yang Z
    J Comp Neurol; 2019 Dec; 527(18):2931-2947. PubMed ID: 31132148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bv8/Prokineticin proteins and their receptors.
    Negri L; Lattanzi R; Giannini E; Melchiorri P
    Life Sci; 2007 Sep; 81(14):1103-16. PubMed ID: 17881008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic landscape of PROKR2 in neuroendocrine disorders.
    Martinez-Mayer J; Perez-Millan MI
    Front Endocrinol (Lausanne); 2023; 14():1132787. PubMed ID: 36843573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EG-VEGF, BV8, and their receptor expression in human bronchi and their modification in cystic fibrosis: Impact of CFTR mutation (delF508).
    Chauvet S; Traboulsi W; Thevenon L; Kouadri A; Feige JJ; Camara B; Alfaidy N; Benharouga M
    Am J Physiol Lung Cell Mol Physiol; 2015 Aug; 309(3):L314-22. PubMed ID: 26047640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
    Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
    Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects of prokineticin 2 in the control of energy metabolism.
    Magnan C; Migrenne-Li S
    Biochimie; 2021 Jul; 186():73-81. PubMed ID: 33932486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.